ISSN: 2157-2518
Journal of Carcinogenesis & Mutagenesis
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

A Working Threshold for Acute Nocturnal Melatonin Suppression from White Light Sources used in Architectural Applications

Mark S. Rea* and Mariana G. Figueiro
Lighting Research Center, Rensselaer Polytechnic Institute, Troy, New York, USA
Corresponding Author : Mark S. Rea, PhD
Lighting Research Center
Rensselaer Polytechnic Institute
Troy, New York 12180, USA
Tel: 518 687 7100
Fax: 518 687 7120
E-mail: ream@rpi.edu
Received July 22, 2013; Accepted September 11, 2013; Published September 20, 2013
Citation: Rea MS, Figueiro MG (2013) A Working Threshold for Acute Nocturnal Melatonin Suppression from “White” Light Sources used in Architectural Applications. J Carcinogene Mutagene 4:150 doi: 10.4172/2157-2518.1000150
Copyright: © 2013 Rea MS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Carcinogenesis & Mutagenesis

Abstract

Retinal light exposures can decrease melatonin production at night. Since nocturnal melatonin suppression by light has been implicated as an endocrine disruptor and linked to certain diseases, such as diabetes, obesity and cancer, it is important to be able to estimate a threshold light level needed to reliably suppress melatonin. The present study was designed to develop a working threshold for melatonin suppression from “white” light that might be experienced by people in their living environments. Twenty-eight subjects participated in two studies. In addition to dark, control nights, subjects were exposed to 8, 22, and 60 lux at the cornea (study 1, n=14) and to 60, 200, and 720 lux (study 2, n=14) of a “warm white” light source (correlated color temperature of 2670 K). These corneal illuminance levels translate to modeled melatonin suppression levels of 1%, 2%, 6%, 19%, and 42%. In both studies, participants came to the laboratory for four nights, separated by one week. One blood sample was drawn in dim light at midnight and another blood sample was drawn after 60-minute exposure to each light condition (including dark). Using an orthodox statistical criterion for a Type I error of α?< 0.05, only the 200 lux and the 720 lux exposures produced significant suppression levels (19% and 37%, respectively). Based upon a criterion modeled suppression level of 5% for a “cool white” light (6500 K), a corneal light exposure of 30 lux for 30 minutes from “white” light sources used in most architectural lighting applications is proposed as a conservative hypothesized working threshold for nocturnal melatonin suppression.

Keywords
Light at night; Melatonin; Phototransduction; Light emitting diodes; Circadian rhythms
Introduction
The master clock in the Suprachiasmatic Nuclei (SCN) in humans is genetically pre-programmed to cycle, on average, every 24.2 hours, although individuals differ in the precise timing of their master clock. For those who work during the day and sleep at night, the master clock is usually synchronized to local time by the light/dark patterns incident on the retina, despite those individual differences. In other words, the daily light/dark pattern provides synchronizing signals to the SCN, which then run on a 24-hour schedule rather than on its preprogrammed period.
Exposure to bright electric lighting at night or dim electric lighting during the daytime, however, can affect the timing of SCN and, thus, circadian rhythms. Lighting technologies and applications for architectural spaces such as the home or the roadway are designed and built to support the human visual system, not our circadian system. Since the biophysical characteristics of light affecting our visual system are markedly different than those affecting our circadian system, exposure to electric lighting, day and night, may disrupt the natural 24-hour circadian cycle. Epidemiological studies have consistently shown, for example, that breast cancer is more likely to occur in nightshift-working women [1-4]. These women most likely experience circadian disruption because they are rarely exposed to a consistent light (at night) and dark (during the day) cycle. To estimate which light exposures throughout the solar day are and are not effective for stimulating the circadian system, it is necessary to characterize the spectral and absolute sensitivities of the human circadian system to retinal light exposures.
Retinal exposure to short-wavelength light of sufficiently high level and long duration will suppress nocturnal melatonin synthesis by the pineal gland via signal from the SCN; nocturnal melatonin suppression is an orthodox marker for circadian system stimulation by light [5-10]. A working threshold for acute melatonin suppression by light is not yet well accepted, however. Posture [11], photic history [12,13], biomarker type, methods for calculating acute melatonin suppression, the pulsatic nature of melatonin production [14], individual differences in preretinal filtering [15], and diet [16] are some of the reasons why it is difficult to define a value that might be taken as “the” threshold amount of light needed to suppress nocturnal melatonin. It is possible, however, to make predictions of the potential effectiveness of different light sources for reaching a criterion amount of nocturnal melatonin suppression using the model proposed by Rea et al. [6,7]. Consistent with published evidence from neurophysiology and neuro-anatomy, and from empirical data on light-induced nocturnal melatonin suppression in humans [8-10], the model incorporates the photopigment melanopsin contained in the Intrinsically-Photosensitive Retinal Ganglion Cells (ipRGCs) [17], as well as the photopigments in rods and cones. The peak spectral sensitivity of nocturnal melatonin suppression is shorter (close to 460 nm) than the peak spectral response of melanopsin (close to 480 nm) in humans. This observed phenomenon is consistent with the postulated retinal neural circuitry in the model whereby the ipRGCs receive depolarizing input from blue versus yellow (b-y) spectrally opponent retinal pathway [18].
Since the model provides quantitative estimates of nocturnal melatonin suppression following one-hour exposures during the early night to any light level or spectral composition, Figueiro et al. [19] proposed a working threshold for measurable melatonin suppression for white light sources commonly used in architectural applications, both indoors and outdoors. A criterion of 15% suppression was chosen, reflecting the 10% uncertainty in reliably measuring melatonin concentrations. This choice was made after examining data from several published studies of nocturnal melatonin suppression [20-22]. Figueiro et al. cautioned that this threshold value would vary for different individuals [23-25] and different spectral irradiance distributions [7], so a more cautious working threshold exposure of 30 lux of “white” light for 30 minutes was proposed [19].
The present study was designed to more closely examine the working threshold proposed by Figueiro et al. [19]. Nocturnal melatonin suppression was measured after one-hour exposures to a white light source of low Correlated Color Temperature (CCT), similar to incandescent lamps presently used in homes in North America, over a range of illumination levels that might be experienced in homes in North America. Based on model calculations, it was hypothesized that exposure to light levels below 30 lux would not result in melatonin suppression reliably different than zero, while the higher light levels could result in measureable suppression.
Participants
Twenty-eight subjects participated in two studies; each ran four consecutive weeks. Fourteen young adults, 7 males and 7 females (mean age ± Standard Deviation (SD)=21.4 ± 1.5 years), with a mean ± SD reported chronotype [26] of 3.1 ± 1.4 participated in the first study. Fourteen young adults, 1 male and 13 females (mean age ± SD=20.5 ± 0.5 years) with a mean ± SD reported chronotype of 3.0 ± 1.9 participated in the second. All subjects, by self-report, were nonsmokers, free from any major health problems, and were not taking any pharmaceuticals. None of the subjects travelled more than two time zones starting one month prior to the study. All subjects completed a consent form approved by Rensselaer’s Institute Review Board and were paid for their participation.
Light Sources
Clear safety goggles were fitted with four Luxeon M3-PW71 (Philips Lumileds Lighting, San Jose, CA) “white” Light Emitting Diodes (LEDs), two per lens, to deliver the prescribed doses of light at the subjects’ corneas. A potentiometer controlled current to the LEDs to adjust the light levels. The LEDs were covered with diffusing tape to reduce discomfort glare [27] and ensure that the maximum blue light hazard-weighted radiance [28] was below the safety threshold of 100 W/(m2 sr); the highest blue light hazard-weighted radiance at the highest current level used in the experiment was 1 W/(m2 sr) as measured with a Pritchard spectroradiometer (PR-705, Photo Research Inc., Chatsworth, CA). The spectral irradiance distribution (measured with an Oriel Instaspec IV spectrometer, Oriel Instruments, Stratford, CT) of the light filtered through the diffusing tape (Figure 1) had a correlated color temperature (CCT) of 2670 ± 29 K.
Light Doses
In 2005, Rea and colleagues proposed a spectral sensitivity function for the human circadian system, followed by a model relating “Circadian Light” (CLA) to a quantity called “Circadian Stimulus” (CS) in 2010 [7,29]. CS should be directly proportional to light-induced nocturnal melatonin suppression, from below threshold to above saturation, for one-hour exposure during the middle of the subjective night. A fixed, 2.3 mm pupil diameter is assumed in the CS calculations. Thus, a calculated value of CS can be considered a predicted amount of nocturnal melatonin suppression resulting from a one-hour exposure to a light stimulus of a given CLA. Values of CS range from 0 to 0.7, representing light-induced nocturnal melatonin suppression from 0% to 70%.
To account for newly published data on light-induced nocturnal melatonin suppression [5,10] and a revised model of the spectral sensitivity of the human circadian system [6], the modeled relationship between CLA and CS was updated for the present study. The new formula for calculating CS from CLA utilizes the original two data sets, Brainard et al. [8] and Thapan et al. [9], and new data on light-induced nocturnal melatonin suppression from Brainard et al. [30], West et al. [10], and Figueiro et al. [5]. As with the original formulation, every corneal irradiance value in the updated data set was transformed into the updated values of CLA. A best-fitting sigmoid function, based upon the formulation used by Zeitzer et al. [31], was then determined to relate CLA to CS using a least-squares criterion. Again, CS is directly proportional to predicted levels of light-induced nocturnal melatonin suppression.
                      (1)
The target corneal illuminance levels chosen for study 1 were 8, 22, and 60 lux. The target corneal illuminance levels chosen for study 2 were 60, 200, and 720 lux. The target and measured illuminances and the measured irradiances are listed in Table 1, as well as the corresponding values of CS. Through the CS calculations (equation 1), the corneal illuminance levels translate to predicted melatonin suppression levels of 0.70%, 2.2%, 6.1%, 19%, and 42%, respectively. Both studies included a dark/control night. Each goggle set was calibrated using the Oriel Instaspec IV.
Methods
All participants were asked to maintain a regular sleep/wake cycle during the four weeks of the study. In addition to wearing actigraphs (Actiwatch-64, Mini-mitter, Bend, OR) on the non-dominant wrist, participants completed a sleep/wake diary for five weeks; during the study and one week prior to it. These diaries documented bedtimes, rising times, caffeine consumption, and quality of sleep during the weeks of the experiment. Sleep logs were verified with the wrist actigraph data. Subjects were asked not to consume any caffeine 12 hours prior to starting data collection on the day of the experiment.
In each study, participants came to the laboratory for four nights, separated by one week. Every night they were asked to arrive at the laboratory at 23:30. The room lights were turned off and subjects remained in dim red light (λmax=630 nm, < 2 lux at the cornea). Blood draws began at midnight (00:00) every study night; the light goggles were energized at 00:15 except on the baseline, dark night. At 01:15 another blood sample was drawn. Before the last blood draw, iris-pupil measurements were taken every study night with a Sony video camera and IMAQ Vision Builder software (version 6.1, National Instruments, Austin, TX) while the goggles were energized; no pupil measurements were taken during the dark night.
Data Analyses
Plasma samples were assayed by radioimmunoassay using a commercially available kit (Labor Diagnostika Nord, Nordhorn, Germany). The limit of detection was 1.9 pg/ml and the intra- and inter-assay coefficients of variability were determined to be 11.4% and 12.7%, respectively.
Adjusted dark values for each study (A) were calculated for each subject to account for their natural rise in melatonin level concentrations (C) while in the dark and for differences in the initial melatonin concentrations week-to-week. Melatonin concentrations obtained from each subject during the initial dark condition (D) at 00:00 were used for the adjusted dark values. Melatonin suppression was calculated for each lighting condition (Lm) using the adjusted dark value at the same sampling time (Tn). The adjusted dark value (A) in a given study for a given lighting condition (Lm) and sampling time (Tn) is given by:
A=(CT1,Lm/CT1,D) CTn,D                                                             (2)
Where: C=melatonin concentration (pg/ml)
T=sampling time, n=1,2
1=00:00 and 2=01:15
L=lighting condition per study, m=1,2,3
In the first study: 1=8 lx, 2=22 lx, 3=60 lx
In the second study: 1=60 lx, 2=200 lx, 3=720 lx
D=dark
Melatonin suppression (S)=100*(1 – [CTn, Lm/A])                         (3)
Two repeated measures, one factor (lighting conditions) analyses of variance (ANOVA) were performed using the melatonin suppressions obtained in both studies. Post hoc, two-tailed, onesample t-tests were also performed to determine whether melatonin suppression at each light level was significantly greater than zero. To reach statistical significance, the criterion probability of a Type 1 error (a) was set at 0.05. All statistical analyses were performed using the PASW Statistics 18.0 (SPSS, Chicago, IL) software.
Results
The ANOVA using data from study 1 did not reveal a significant main effect of light level (F2,24=1.9; α=0.12). The ANOVA using data from study 2 revealed a significant main effect of light level (F2,24=12.8; α <0.0001). The mean suppression values and the associated 95% confidence intervals are shown in Figure 2. Confidence intervals are used as indices of measurement uncertainty to determine if zero suppression (i.e., absolute threshold) is included in the range of uncertainty. The relationship between CS and CLA (equation 1) is also shown in Figure 2, but, importantly, is plotted independent of the data collected for the present experiment.
Using data obtained in study 2, paired two-tailed t-tests revealed that melatonin suppression after exposure to 60 lux was significantly less than suppression after 200 lux and 720 lux (α = 0.02 and α = 0.001, respectively). Two-tailed, one sample t-tests showed that melatonin suppression after 60-minute exposure to 200 lux and 720 lux were significantly different than zero (t(13)=2.9; α = 0.01 and t(13)=6.4;α < 0.0001, respectively), while suppression after 60 lux (t(13=0.7; α =0.5 for study 1 and t(13)=1.1; α =0.3 for study 2), 22 lux (t(13)=-1.1; α =0.3), and 8 lux (t(13)=0.7; α =0.5) were not statistically significantly different than zero. These results from the inferential statistics are consistent with the 95% confidence interval descriptive statistics. Table 2 summarizes the empirical findings and the independent, associated model predictions.
Discussion
The present results show a dose-response characteristic for nocturnal melatonin suppression for different corneal light exposures that is consistent with the updated model predictions from Rea and colleagues [6,7]. The measured levels of light-induced nocturnal melatonin suppression obtained in the second study from one-hour exposures to 200 lux and 720 lux were very close to the calculated CS values as was the calculated CS at 60 lux from the first study. The low suppression levels for 8 lux, 22 lux, and 60 lux (study 2) were, in fact, negative, meaning that measured melatonin concentrations following one-hour exposure to these levels of light were higher than those measured in the dark. Based upon the orthodox criterion probability for a Type I error used in inferential statistics (i.e., α < 0.05), a one-hour exposure to 200 lux at the cornea from the “warm white,” polychromatic light used in the present study was needed to reliably suppress nocturnal melatonin; obviously too, the higher level, 720 lux, was also significant at α < 0.05. The 95% confidence intervals also do not include zero suppression for the 200 lux and the 720 lux exposures, so exposure to a corneal irradiance of 200 lux (or higher) from this light source for one hour will reliably suppress nocturnal melatonin.
However, given the inherent conservative nature of inferential statistics (i.e., low α with an associated bias against false positives), 200 lux is probably too high a light level to be considered as a working threshold for those individuals concerned more with misses than with false positives. Specifically, many are concerned that even small amounts of suppression may lead to negative health outcomes [32,33] and a working threshold of 200 lux (for one hour) would be too high because some melatonin might be suppressed. This is a legitimate concern because threshold is a construct based upon the physiological stimulus-response characteristics of a biological system in addition to perceived risk of misses and false positives [34]. Therefore, it is important to formally decide on a statistical criterion for a Type II error, the probability (α) of a miss, as well as the probability of a Type I error (α) when proposing a working threshold for light-induced nocturnal melatonin suppression.
Type II errors are directly related to statistical power (P), whereby P=1 -β In addition to the empirical results from this study and the model predictions, Table 2 shows the sample sizes needed to reach statistical criteria of α < 0.05 and β < 0.05. As can be seen, for light levels less than 200 lux, very large sample sizes would be needed to meet these stringent statistical criteria biased against both false positives and misses. Considering (a) that the uncertainty in melatonin assays are approximately 10% to 15%, (b) that the two estimated suppression levels from one-hour exposure of 60 lux for this light source were within that range, and (c) that both positive suppression (study 2) and negative suppression (study 1) were observed for a one-hour exposure to 60 lux, it seems rather unlikely that a new study employing 400 subjects (or more) would, in fact, lead to a statistically reliable (β < 0.05 and α < 0.05) level of nocturnal melatonin suppression from one-hour exposure to 60 lux from this light source. Therefore, another method for estimating a working threshold is needed, albeit one consistent with inferential statistics.
Using equation 1 and the updated model by Rea and colleagues [6], three levels of CS, 0.05, 0.10, and 0.15, were chosen to frame considerations of a working threshold for “white” light. Two light sources were used, the one used in the present study (2670 K) and a 6520 K LED (Luxeon ML-PW51 [Philips Lumileds Lighting, San Jose, CA] with a diffuser [Roscolux “Tough White Diffusion” #116, Rosco, Stamford, CT] and blue filter [Roscolux “Full Blue” #3202, Rosco, Stamford, CT] attached). These two sources represent the entire range of electric light source CCTs manufactured and sold as “white” illumination for architectural lighting [35]. Table 3 shows the estimated photopic illuminance levels incident on the cornea for one hour that would be needed to achieve CS values of 0.05, 0.10, and 0.15 from these two light sources.
Assuming a working threshold based upon CS=0.05, then it would take a one-hour corneal light exposure of 50 lux from the “warm white” source or of 26 lux from the “cool white” source to induce approximately 5% suppression of melatonin at night. In choosing a criterion suppression level for a working threshold of light exposure, it is necessary to consider the levels of corneal light exposures that people actually experience in their homes at night to meet their personal needs for safety, reading, watching television and socializing; a working threshold for light exposure set too low may, in fact, compromise human comfort, visual needs, and safety in the home [36].
Despite stated concerns for electric light sources in the home as they might pose health risks from melatonin suppression at night [37-39], very few data have been reported concerning actual light exposures in living and working environments. Figueiro et al. [40] reviewed data collected from several studies that utilized the Daysimeter, a personal light exposure meter calibrated in terms of photopic illuminance (lux), CLA, and CS. That review showed that the median of the mean photopic illuminance levels and the median of the mean CS levels for evening light exposures in five different populations (teachers, eighth grade students, young adults, day-shift nurses, and rotating-shift nurses) were 63 lux and 0.046, respectively, suggesting that, on average, evening light exposures could result in nocturnal melatonin suppression of approximately 5%. The highest mean CS level for evening light exposures was 0.07, which was associated with the rotating-shift nurses who, among the groups examined here, are known to be at higher risk for breast cancer.
Depending then upon one’s own perspective with regard to misses or false positives, these measured levels of evening light may or may not be considered a health risk. A great deal more data will have to be collected and analyzed (considering both false positives and misses) to establish a more precise threshold light exposure for nocturnal melatonin suppression. Nevertheless, in the public interest, it seems incumbent upon the scientific community to establish a hypothesized working threshold for light exposure at night until much more data are collected and analyzed.
Here we propose, for further testing, that the hypothesized working threshold for acute nocturnal melatonin suppression be 30-minute exposure to a 30 lux at the cornea from “white” light sources that might be used in architectural applications. These values represent a conservative estimate of dose, recognizing that the empirical results of the present studies and the traditional probability of a Type I error (i.e., a < 0.05), a one-hour exposure to 200 lux from the selected “warm white” light source would be the lowest lighting condition that could reliably suppress nocturnal melatonin synthesis. Although a lower exposure level could be considered as the working threshold, it should be recalled that 60 lux did not reliably suppress melatonin in either of the two studies. Given our own concerns for health risk and our field measurements of actual light exposures in the home [40,41] we believe that a one-hour exposure to even 60 lux of “white” light is too high as a working threshold. Rather, given (a) the consistency between the empirical results presented here and the model predictions of CS (Figure 2), (b) the field measurements of actual light exposures [40,41], and (c) our own concerns for public health (i.e., a bias against misses), we concluded that our earlier proposal of 30 lux for 30 minutes from “white” light can still be used as a working threshold for lightinduced nocturnal melatonin suppression. This exposure level should limit, on average, nocturnal melatonin suppression to less than 5% (i.e., CS < 0.05), a value within the uncertainty of measuring melatonin concentrations using current radioimmunoassay methods.
The present results are relevant for the discussion about LAN as an endocrine disruptor. The incidence of breast cancer has continuously increased in modern industrialized society and is the most frequently diagnosed malignant disease in women of all ethnic groups in the United States and Northern Europe. The reasons for this increase in breast cancer incidence are still unknown, but it is well accepted that breast cancer risk is affected by endogenous factors, such as the concentration levels of melatonin, estrogen, testosterone, and insulin-growth factors (IGF). An important consideration for understanding the increased incidence of breast cancer is the disruption of regular circadian rhythms associated with living in a modern society. Disruption to the circadian cycle, either by melatonin depletion or by irregular light/ dark cycles, has been shown to increase tumor growth and mortality in animal models [42-46]. Therefore, further investigating the threshold for acute melatonin suppression and disruption of circadian rhythms is an important first step towards better understanding the effects of LAN on diseases.
Acknowledgements
The authors would like to thank Andrew Bierman, Dennis Guyon, Robert Hamner, Sharon Lesage, Anna Lok, Ines Martinovic, Barbara Plitnick, and Brittany Wood from the Lighting Research Center for their support. This research was supported by the Office of Naval Research (grant # N00014-11-1-0572) and the Engineering Research Centers Program of the National Science Foundation under NSF Cooperative Agreement No. EEC-0812056, in part by New York State under NYSTAR contract C090145.
References

Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc
Disc Adenocarcinoma pancreas
Disc Advances in Alternative Lung Cancer Treatment
Disc Anti-Cancer Drug
Disc Apoptosis
Disc Bone Cancer Stages
Disc Bone Marrow Cancer Survival
Disc Bone cancer
Disc Brain Tumor Treatment
Disc Cancer Science
Disc Cancer Therapeutics
Disc Cancer Therapies
Disc Cancer initiation and progression
Disc Cancer therapy
Disc Carcinogenesis
Disc Carcinoma Case Reports
Disc Chemo Resistance
Disc DNA damage
Disc Ductal adenocarcinoma
Disc Electro Chemotherapy
Disc Esophageal Cancer
Disc Gynecological Cancers
Disc Gynecological Oncology
Disc Hematology Case Reports
Disc Integrative Medicine
Disc Kidney Cancer Prognosis
Disc Liver Cancer Case Reports
Disc Lung Cancer Case Reports
Disc Lung Tumor
Disc Lungs Cancer Cure
Disc Lymph Node Cancer
Disc Lymphomatous polyposis
Disc Mutagenesis
Disc Neoplasm
Disc Oncogenes
Disc Oseophagus Cancer
Disc Ovarian Cancer and Prognosis
Disc Pancreatic Cancer
Disc Photo carcinogenesis
Disc Prostate Breast
Disc Radiation Therapy Case Reports
Disc Radiotherapy
Disc Sarcoma Cancer
Disc Skin Cancer
Disc Squamous Cell Carcinoma
Disc Tumorigenesis
 
Recommended Journals
Disc Medical Oncology Journal
Disc Carcinoma Journal
Disc Neuro Oncology Journal
Disc Head & Neck Cancer Journal
Disc Colorectal Cancer Journal
Disc Cancer Research Journal
Disc Oncology Journal
Disc Cancer Journal
Disc Chemotherapy Journal
  View More»
 
Recommended Conferences
Disc 10th Oncologists Summit
July 11-13, 2016, Cologne, Germany
Disc Oral , Mouth and Throat Cancer
Aug 18-20, 2016, Portland, Oregon
Disc 3rd World Congress on Women’s Health and Breast Cancer
Crowne Plaza London – Heathrow October 03-05, 2016 London, UK
Disc Mesothelioma Conference
Nov 3-4, 2016, Valencia, Spain
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11238
  [From(publication date):
October-2013 - May 30, 2016]
  Breakdown by view type
  HTML page views : 7512
  PDF downloads :3726
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version